Across TCGA pan-cancer cohorts, PPIAP77 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated PPIAP77 data layer.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher PPIAP77 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated PPIAP77 expression acts as an unfavorable survival marker, although some lineages such as LUSC and HNSC show a favorable association.
ACC, LUSC, and STAD are the cancer types where PPIAP77 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.